Skip to main content
TipRanks
Go Ultimate75% OFF

SenesTech (SNES) AI Stock Analysis

358 Followers
SNES

SenesTech

(NASDAQ:SNES)

Select Model
Rating:45Neutral
Price Target:$1.00▲(16.01% Upside)
Action:reiterated
Date:11/11/26

The score is held down primarily by weak financial performance—large ongoing losses, heavy cash burn, and equity erosion—despite improving gross margins and revenue growth. Technicals are moderately supportive near-term but the longer-term trend remains weak. Earnings call commentary was mixed: strong growth and operational progress, but persistent unprofitability, dilution concerns, and no profitability timeline. Valuation provides limited support given negative earnings and no dividend yield.

Positive Factors
Revenue GrowthRecord revenue and consecutive quarterly growth indicate increasing commercial adoption of SenesTech’s rodent-control products. Continued expansion can improve operating leverage over time, while stronger demand supports broader channel development and creates a larger base for future recurring sales.
Negative Factors
Persistent Cash BurnLarge, persistent negative operating and free cash flow means the company is not yet self-funding its operations. Continued cash consumption can constrain investment flexibility and increase dependence on financing, making execution and revenue growth especially important over the next several quarters.

SenesTech (SNES) vs. SPDR S&P 500 ETF (SPY)

-80%-60%-40%-20%0%20%SNES-68.77%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$4.57M
Dividend Yield
―
Average Volume (3M)
1.05M
Price to Earnings (P/E)
-0.6
Beta (1Y)
1.38
Revenue Growth
20.86%
EPS Growth
60.44%
Country
US
Employees
24
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

SenesTech Business Overview & Revenue Model

Company Description

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxi...

How the Company Makes Money

SenesTech makes money primarily by selling its rodent fertility control products (commercialized as ContraPest) to customers involved in rodent control and pest management. Revenue is generated through product sales into professional pest control cha...

SenesTech Earnings Call Summary

Earnings Call Date:Nov 10, 2026(Q3-2026)|% Change Since:-16.31%|Next Earnings Date:Mar 18, 2027
Earnings Call SentimentPositive

The call was predominantly positive, supported by record revenue and gross profit, strong ecommerce and subscription growth, improving operating cash use, expanding B2B capacity, and encouraging municipal results. However, the company remains unprofitable, continues to report significant operating expenses and cash usage, has not provided a profitability timeline, and faces shareholder concerns regarding ATM financing and dilution. Management also acknowledged that consumer education, pricing, and subscription structures still require optimization.

Positive Updates

First Quarterly Revenue Above $1 Million
Third-quarter revenue reached approximately $1.1 million, up 42% from $770,000 in the second quarter of fiscal 2026 and 59% from $690,000 in the third quarter of 2025. Management described this as the company's first quarter above $1 million and its second consecutive quarterly revenue record.

Negative Updates

Continued Net Loss
Third-quarter net loss was approximately $2.2 million, or $0.36 per share, compared with $1.8 million, or $0.32 per share, in the second quarter and $1.3 million, or $0.28 per share, in the third quarter of 2025.

Company Guidance

Management said it expects to add at least 1 more salesperson before the end of the year, with the B2B team moving from 2 sales reps in the field to “5, hopefully, by the end of the year”; pricing and subscription model changes are expected in Q4 and Q1, while pipeline-building activities are underway as the company moves into Q1 and Q2. Management said B2B could “far exceed” ecommerce as the company expands its team and territories in 2027 and 2028, but said it does not provide future guidance on EBITDA breakeven or specific revenue levels.

SenesTech Financial Statement Overview

Summary

Despite improving unit economics (material gross margin expansion and revenue growth), SNES remains in a very weak profitability and cash-flow position: large operating and net losses persist and operating/free cash flow are strongly negative, indicating continued reliance on external funding. The balance sheet is not highly levered, but equity erosion and ongoing cash burn are key risks.

Income Statement

18Very Negative

Balance Sheet

41Neutral

Cash Flow

14Very Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.78M2.22M1.86M1.19M1.02M576.00K
Gross Profit1.90M1.39M1.00M539.00K464.00K220.00K
EBITDA-7.58M-6.23M-6.01M-7.57M-9.51M-7.95M
Net Income-7.66M-6.38M-6.18M-7.71M-9.70M-8.27M
Balance Sheet
Total Assets8.14M12.84M3.28M7.29M6.78M11.50M
Cash, Cash Equivalents and Short-Term Investments3.95M8.57M1.31M5.39M4.78M9.33M
Total Debt2.53M2.68M262.00K406.00K359.00K555.00K
Total Liabilities3.54M3.27M767.00K942.00K1.50M1.47M
Stockholders Equity4.60M9.57M2.51M6.35M5.28M10.04M
Cash Flow
Free Cash Flow-6.66M-5.89M-6.12M-7.71M-8.75M-7.88M
Operating Cash Flow-6.63M-5.75M-6.03M-7.57M-8.58M-7.78M
Investing Cash Flow1.97M-1.10M-56.00K-149.00K-170.00K-99.00K
Financing Cash Flow155.00K13.12M2.00M8.34M4.20M13.56M

SenesTech Technical Analysis

Technical Analysis SentimentNegative
Last Price0.86

Price Trends

50DMA0.84Positive
100DMA1.09Negative
200DMA1.43Negative

Market Momentum

MACD0.04Positive
RSI44.64Neutral
STOCH19.05Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SNES, the sentiment is Negative. The current price of 0.86 is below the 20-day moving average (MA) of 0.96, above the 50-day MA of 0.84, and below the 200-day MA of 1.43, indicating a neutral trend. The MACD of 0.04 indicates Positive momentum. The RSI at 44.64 is Neutral, neither overbought nor oversold. The STOCH value of 19.05 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SNES.

SenesTech Risk Analysis

SenesTech disclosed 31 risk factors in its most recent earnings report. SenesTech reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

1 New Risk
1.We could be required to collect additional sales, value added or similar taxes or be subject to other tax liabilities that may increase the costs our clients would have to pay for our products and adversely affect our results of operations.Q4, 2025

SenesTech Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

SNES against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
BCPCBCPC79Outperform$5.50B32.4213.21%0.55%9.42%16.31%
ECLECL72Outperform$86.74B41.7420.70%0.94%9.33%5.71%
ESIESI62Neutral$8.03B39.147.39%0.97%39.62%-14.83%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
PRMPRM58Neutral$4.81B104.864.74%―30.67%-46.70%
SCLSCL55Neutral$1.51B349.370.36%2.38%10.02%-90.50%
SNESSNES45Neutral$4.68M-0.59-109.68%―20.86%60.44%

* Basic Materials Sector Average

Performance Comparison

-50%0%50%SNESBCPCECLSCLESIPRMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SNES and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SNESSenesTech0.86-1.92-68.99%
BCPCBalchem173.1418.5612.01%
ECLEcolab309.2756.5722.38%
SCLStepan Company66.3824.9860.33%
ESIElement Solutions33.088.3833.91%
PRMPerimeter Solutions, Sa29.363.7314.55%

SenesTech Corporate Events

Business Operations and StrategyDelistings and Listing ChangesFinancial DisclosuresRegulatory Filings and Compliance

SenesTech Reports Record Q3 Revenue and Shareholder Support

Negative
Oct 22, 2026

On October 20, 2026, SenesTech received notice from Nasdaq that its common stock had closed below the $1.00 minimum bid price for 30 consecutive business days, putting the company out of compliance with listing rules. The shares remain trading on the...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 11, 2026